Back to results
US 11,078,195 B2Granted
Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
AssigneeCheckmate Therapeutics Inc.
InventorsHyun Seok Kim, Gyoon Hee Han
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel compounds for inhibiting nicotinamide phosphoribosyltransferase (NamPT), a composition comprising the same, and various uses thereof.
Claims4
A compound selected from a compound represented by following Chemical Formula 5, a pharmaceutically acceptable salt, an optical isomer, a hydrate and a solvate thereof:
- wherein in Chemical Formula 5,
- X1 is N;
- X2 is C(H);
- p is an integer of 1 to 3;
- L6 is a direct bond;
- and
- R17 is represented by Chemical Formulae 3, a1 or a4:
- in Chemical Formula 3,
- Y1 is O;
- Y2 is N;
- Z1, Z2 and Z4 are C(H);
- R21 is hydrogen or C1˜C6 alkyl group;
- Z3 is C(C1˜C6 alkyl;
- wherein in Chemical Formula a1,
- * is a bonding site;
- o is an integer of 0 to 2;
- R23 can be selected from the group consisting of halogen, nitro group, C6˜C14 alkyl group, in case that the R23 is plural, they can be the same as or different from each other;
- wherein in Chemical Formula a4,
- * is a bonding site;
- O is an integer of O or 2;
- R23 is selected from the group consisting of a halogen, a nitro group and C6˜C14 aryl group, in case that the R23 is plural, they can be the same as or different from each other.
18 more elements
Dependencies are inferred from the claim text.